Circulating inflammatory cytokines in relation to the risk of renal cell carcinoma: A gender‐specific two‐sample Mendelian randomization study
Open Access
- 30 October 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (22) , 21013-21021
Abstract
Background: Currently there is no specific molecular biomarker for the diagnosis and treatment of renal cell carcinoma (RCC). Here we performed a gender‐specific two‐sample Mendelian randomization analysis to systematically assess the effects of circulating cytokines on RCC.Methods: We have employed cis‐quantitative trait loci as instrumental variables for the protein levels and expression of circulating cytokines. We estimated the causal effects of circulating cytokines on RCC risk in males and females with several Mendelian randomization methods.Results: We observed a significant causal effect of Eotaxin on the increased risk of RCC in males (Odds ratio [OR] = 2.546, 95% confidence interval [CI] = 1.617–4.010, p value = 5.496 × 10–5), but not in females (OR = 1.352, 95% CI = 0.766–2.388, p value = 0.298). Besides, we also identified several cytokines as potentially associated with RCC in males including RANTES, MCP3, PDGFbb, TRAIL, and several other cytokines as potentially associated with RCC in females including sICAM and SCGFb.Conclusion: Our study highlighted that a higher level of circulating Eotaxin is causally associated with an increased risk of RCC in males but not in females. Further studies are needed to elucidate the exact mechanism and its potential application in the prognosis and treatment of RCC.Keywords
This publication has 34 references indexed in Scilit:
- MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized dataInternational Journal of Epidemiology, 2017
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorGenetic Epidemiology, 2016
- International Variations and Trends in Renal Cell Carcinoma Incidence and MortalityEuropean Urology, 2015
- Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expressionOncology Reports, 2014
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trialsThe Lancet Oncology, 2012
- Immunity, Inflammation, and CancerCell, 2010
- Up-Regulation of Functional Chemokine Receptor CCR3 in Human Renal Cell CarcinomaClinical Cancer Research, 2005
- Prostatitis as a Risk Factor for Prostate CancerEpidemiology, 2004
- Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophiliaOral Diseases, 2003
- Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphomaBlood, 2003